Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-25 @ 12:25 PM
NCT ID:
NCT02156895
Recruitment Details:
Participants with advanced renal cell carcinoma (aRCC) prescribed with Inlyta (axitinib) for first time or who were already on Inlyta during study period as part of routine practice at Korean health care centers were observed. This study was to be conducted for 6 years from the approval date of 22 Aug 2012 to 21 Aug 2018. On May 2018, Ministry of Food and Drug Safety (MFDS) has granted 3 additional years for the study, for total of 9 years for the study period.
Study:
NCT02156895
Study Brief:
Results Section:
NCT02156895